pyroglutamyl-histidyl-glycine has been researched along with Colonic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lachowicz, A; Pawlikowski, M; Stepień, H; Szadowska, A; Winczyk, K; Zerek-Mełeń, G | 1 |
| Paulsen, JE | 1 |
| Reichelt, KL; Skraastad, O | 1 |
3 other study(ies) available for pyroglutamyl-histidyl-glycine and Colonic Neoplasms
| Article | Year |
|---|---|
Failure of tripeptide colon mitosis inhibitor to suppress the cell proliferation of dimethylhydrazine-induced colonic cancers in rats.
Topics: Adenocarcinoma; Adenoma; Amino Acid Sequence; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Dimethylhydrazines; Growth Inhibitors; Hyperplasia; Intestinal Mucosa; Male; Molecular Sequence Data; Oligopeptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar | 1993 |
The synthetic colon peptide pyroGlu-His-GlyOH inhibits growth of human colon carcinoma cells (HT-29) transplanted subcutaneously into athymic mice.
Topics: Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Injections, Subcutaneous; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Pyrrolidonecarboxylic Acid; Time Factors; Tumor Cells, Cultured | 1993 |
An endogenous colon mitosis inhibitor reduces proliferation of colon carcinoma cells (HT 29) in serum-restricted medium.
Topics: Cell Division; Colon; Colonic Neoplasms; Culture Media; Humans; Mitosis; Oligopeptides; Pyrrolidonecarboxylic Acid; Tumor Cells, Cultured | 1989 |